Phase II trial of 6-diazo-5-oxo-L-norleucine versus aclacinomycin-A in advanced sarcomas and mesotheliomas (Q40765407)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	Phase II trial of 6-diazo-5-oxo-L-norleucine versus aclacinomycin-A in advanced sarcomas and mesotheliomas	scientific article

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2188926

retrieved

23 September 2017

title

Phase II trial of 6-diazo-5-oxo-L-norleucine versus aclacinomycin-A in advanced sarcomas and mesotheliomas (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2188926

retrieved

23 September 2017

main subject

phase II clinical trial

0 references

author name string

R H Earhart

series ordinal

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2188926

retrieved

23 September 2017

D J Amato

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2188926

retrieved

23 September 2017

A Y Chang

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2188926

retrieved

23 September 2017

E C Borden

series ordinal

4

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2188926

retrieved

23 September 2017

M Shiraki

series ordinal

5

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2188926

retrieved

23 September 2017

M E Dowd

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2188926

retrieved

23 September 2017

R L Comis

series ordinal

7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2188926

retrieved

23 September 2017

T E Davis

series ordinal

8

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2188926

retrieved

23 September 2017

T J Smith

series ordinal

9

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2188926

retrieved

23 September 2017

publication date

1 February 1990

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2188926

retrieved

23 September 2017

published in

Investigational New Drugs

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2188926

retrieved

23 September 2017

volume

8

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2188926

retrieved

23 September 2017

issue

1

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2188926

retrieved

23 September 2017

page(s)

113-119

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2188926

retrieved

23 September 2017

cites work

Phase II study of elliptinium in metastatic soft tissue sarcoma.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2188926

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Preliminary clinical study of aclacinomycin A

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2188926

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical study of aclacinomycin A

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2188926

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of azotomycin in sarcomas

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2188926

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Azaserine, DON, and azotomycin: three diazo analogs of L-glutamine with clinical antitumor activity

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2188926

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cyclophosphamide versus ifosfamide: final report of a randomized phase II trial in adult soft tissue sarcomas

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2188926

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Metastatic Patterns in Soft-Tissue Sarcomas

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2188926

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clinical drug development: an analysis of phase II trials, 1970-1985

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2188926

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The randomization and stratification of patients to clinical trials

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2188926

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Patterns of recurrence in patients with high-grade soft-tissue sarcomas

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2188926

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A randomized trial for the treatment of high-grade soft-tissue sarcomas of the extremities: preliminary observations

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2188926

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I study of 6-diazo-5-oxo-L-norleucine (DON).

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2188926

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Structure-activity relationships of anthracyclines relative to effects on macromolecular syntheses

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2188926

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Azotomycin (NSC-56654): biologic fate in mice and man

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2188926

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacological and initial therapeutic observations on 6-diazo-5-oxo-1-norleucine (DON) in human neoplastic disease

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2188926

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of azotomycin (NSC-56654)

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2188926

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evaluation of bleomycin, chlorozotocin, MGBG, and bruceantin in patients with advanced soft tissue sarcoma, bone sarcoma, or mesothelioma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2188926

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II trial of anguidine in patients with sarcomas unresponsive to prior chemotherapy: A Southwest Oncology Group Study.

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2188926

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

N-(Phosphonacetyl)-l-aspartate (PALA) in advanced soft tissue sarcoma: a phase II trial of the EORTC soft tissue sarcoma group

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2188926

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Carminomycin vs adriamycin in advanced soft tissue sarcomas: an EORTC randomised phase II study

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2188926

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

High-dose alkylation therapy using ifosfamide infusion with mesna in the treatment of adult advanced soft-tissue sarcoma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2188926

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adjuvant chemotherapy for osteosarcoma: a randomized prospective trial

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2188926

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I trial of 6-diazo-5-oxo-L-norleucine (DON) administered by 5-day courses

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2188926

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Adult soft tissue sarcomas. A pattern of care survey of the American College of Surgeons

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2188926

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fludarabine phosphate. Phase II evaluation in advanced soft-tissue sarcomas

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2188926

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New antitumor antibiotics, aclacinomycins A and B

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2188926

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemotherapy of advanced soft-tissue sarcomas in adults

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2188926

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemotherapy for soft tissue sarcoma

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2188926

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of aclarubicin in previously untreated patients with advanced soft tissue sarcoma: a Southeastern Cancer Study Group trial

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2188926

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prospective randomized evaluation of adjuvant chemotherapy in adults with soft tissue sarcomas of the extremities

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/2188926

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1007/BF00216936

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2188926

retrieved

23 September 2017

Dimensions Publication ID

1045785827

0 references

PubMed publication ID

2188926

1 reference

stated in

Europe PubMed Central

PubMed publication ID

2188926

retrieved

23 September 2017

ResearchGate publication ID

20966984

0 references

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40765407&oldid=2203961330"